Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Economy & Forex  >  All News

News : Economy & Forex

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
All NewsEconomyCurrencies / ForexCryptocurrenciesEconomic EventsPress releases

Pfizer settles New York probe into 'deceptive' copay coupons

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/12/2018 | 02:12pm CET
The Pfizer logo is seen at their world headquarters in New York

NEW YORK (Reuters) - Pfizer Inc on Thursday settled charges by New York's attorney general that it misled consumers in its drug copayment coupon program into thinking they would pay far less to fill prescriptions than they ended up having to shell out.

The drugmaker agreed to pay $500,000 in fines and costs, and make more than $200,000 in restitution over the coupons, which can help consumers burdened by health insurance plans that carry high copayments and deductibles.

Pfizer's coupons said consumers would "PAY NO MORE THAN" $15, $20 or $25 for Estring to treat vaginal atrophy, Quillivant XR and Quillichew ER for attention deficit hyperactivity disorder, and Flector patches for acute pain from minor injuries.

New York Attorney General Barbara Underwood said this was "deceptive" because Pfizer buried limits on the total savings in the small print, and that thousands of consumers ended up paying much more.

Underwood said one woman got a surprise at her pharmacy register when she was required to pay $144.62 for Estring instead of the promised $15 maximum.

The settlement resolves claims from 2014 to 2017, and Underwood said the rate at which New York consumers paid more than the advertised maximums went up over time.

Pfizer changed the text of its coupons this year to say consumers could "pay as little as" specified amounts.

The New York-based company acknowledged some of the attorney general's findings but did not admit or deny liability.

Pfizer confirmed the settlement, and said reimbursements will go to consumers who used coupons in the last three years.

It refunded $129.62 to the woman who paid $144.62 for Estring after the attorney general's office intervened, according to a footnote in the settlement agreement.

(Reporting by Jonathan Stempel in New York; editing by Bill Berkrot)

By Jonathan Stempel

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Economy & Forex"
11:33aFinland cuts debt for the first time in decade
RE
11:15aGERMANY PLANS TO LOWER THRESHOLD FOR PROBES OF FOREIGN TAKEOVERS : Handelsblatt
RE
11:03aFrench budget deficit seen at 3.4 percent of GDP next year
RE
10:20aS&D OF PROGRESSIVE ALLIANCE OF SOCIALI : Progress on technical rules, but more concrete climate action is needed, say S&D's after COP24 draws a close
PU
09:04aJapan plans to cut JGB issuance for sixth straight year - sources
RE
07:25aQE QATAR EXCHANGE : DOHA BANK OUTLOOK UPGRADED TO “STABLE” & RATING REAFFIRMED BY STANDARD & POOR (S&P) (2018-12-16)
PU
04:53aMexican President Proposes Moderate Spending Increase for 2019 -- Update
DJ
02:25aMexican President Proposes Moderate Spending Increase for 2019
DJ
02:03aMexico's new government sees income, spending jump in first budget
RE
01:15aPRESS RELEASES : On EU Resolve in Holding Russia Accountable
PU
Latest news "Economy & Forex"
Advertisement